UBS Group’s Neumora Therapeutics NMRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$477K Sell
2025
Q1
$3.11M Buy
2024
Q4
$13.2M Buy
2024
Q3
$4.49M Buy
2024
Q2
$2.91M Buy
2024
Q1
$348K Buy
2023
Q4
$4.37K Buy